- Trials with a EudraCT protocol (89)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
89 result(s) found for: Oocyte.
Displaying page 1 of 5.
| EudraCT Number: 2017-004433-93 | Sponsor Protocol Number: RIOTCSTUDY22017 | Start Date*: 2018-05-01 | ||||||||||||||||
| Sponsor Name:Nicholas Stephen Macklon, Professor, MD, PhD | ||||||||||||||||||
| Full Title: RIOT C: REDUCING THE IMPACT OF OVARIAN STIMULATION. NOVEL APPROACHES TO LUTEAL SUPPORT IN IVF. STUDY 2. | ||||||||||||||||||
| Medical condition: Ovarian stimulation in oocyte donation | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Female | |||||||||||||||||
| Trial protocol: DK (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2012-000269-19 | Sponsor Protocol Number: 11E/FSH03 | Start Date*: 2012-12-20 | |||||||||||
| Sponsor Name:IBSA, Institute Biochimique S.A. | |||||||||||||
| Full Title: Prospective, open-label, uncontrolled clinical trial evaluating multiple controlled ovarian hyperstimulation cycles in oocyte donor, to assess the immunogenicity of FSH-IBSA | |||||||||||||
| Medical condition: Female infertility | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: ES (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2019-001343-44 | Sponsor Protocol Number: IB-0319-002 | Start Date*: 2019-05-21 |
| Sponsor Name:Instituto Bernabeu | ||
| Full Title: Conventional ovarian stimulation vs. stimulation with single injection of Corifollitropin alfa in oocyte donors. Randomized clinical trial. Tail Studio | ||
| Medical condition: Oocyte donation | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2017-005005-12 | Sponsor Protocol Number: D2.D12.Bemfola | Start Date*: 2018-05-28 | ||||||||||||||||
| Sponsor Name:UZ Brussel | ||||||||||||||||||
| Full Title: Initiation of ovarian stimulation with recombinant-human FSH (Bemfola®) in the late follicular phase, a randomised controlled study. | ||||||||||||||||||
| Medical condition: Subfertility Oocyte donation | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Female | |||||||||||||||||
| Trial protocol: BE (Completed) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2022-003049-37 | Sponsor Protocol Number: CS-10459 | Start Date*: 2022-11-23 |
| Sponsor Name:UZ Brussel | ||
| Full Title: Luteal phase ovarian stimulation with Follitropin delta and dydrogesterone: a randomized cross over pilot trial | ||
| Medical condition: Volutary women who wish to donate their oocytes | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: BE (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-009429-26 | Sponsor Protocol Number: local 997 (P06034) | Start Date*: 2010-03-15 |
| Sponsor Name:FREE UNIVERSITY OF BRUSSELS | ||
| Full Title: A PILOT STUDY TO EVALUATE THE EFFECT OF TRIGGERING FINAL OOCYTE MATURATION WITH GnRHa OR hCG ON ENDOMETRIAL RECEPTIVITY PARAMETERS AND THE LUTEAL PHASE IN OOCYTE DONORS | ||
| Medical condition: Compare the endometrium of oocyte donors, who had final oocyte maturation with either hCG, Suprefact, followed by hCG 35 hours after triggering, Suprefact or Suprefact without luteal phase support.... | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2015-004328-73 | Sponsor Protocol Number: BRAKE | Start Date*: 2016-05-24 |
| Sponsor Name:Fundació Privada EUGIn | ||
| Full Title: Evaluation of efficacy and safety of medroxiprogesterone acetate (Progevera 10 mg®) versus GnRh antagonist (Orgalutran®) in ovarian stimulation cycles of oocyte donors | ||
| Medical condition: Infertility | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-005208-20 | Sponsor Protocol Number: 2019DEPO-TRIGGER001 | Start Date*: 2022-08-10 | |||||||||||
| Sponsor Name:Universitair Ziekenhuis Brussel | |||||||||||||
| Full Title: Depo-Trigger trial: GnRH agonist DEPOt TRIGGER for final oocyte maturation in breast cancer patients undergoing fertility preservation: a pilot study. | |||||||||||||
| Medical condition: Female patients with breast cancer | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: BE (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2013-000801-21 | Sponsor Protocol Number: 20130218 | Start Date*: 2014-08-26 |
| Sponsor Name:Academic Medical Center | ||
| Full Title: Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: alternative versus standard stimulation protocols; the STIM-trial | ||
| Medical condition: Ovarian stimulation in women with breast cancer prior to chemotherapy | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-003779-31 | Sponsor Protocol Number: BER-FSH-2015-01 | Start Date*: 2015-12-04 | |||||||||||
| Sponsor Name:INSTITUTO BERNABEU | |||||||||||||
| Full Title: Prospective, Randomized Open Trial to Evaluate the Efficacy of Highly Purified Urinary FSH (Fostipur®, IBSA) versus Recombinant FSH (Bemfola® Finox) in Oocyte Donors Undergoing Controlled Ovarian S... | |||||||||||||
| Medical condition: Ovarian stimulation for oocyte donation. | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2022-002678-10 | Sponsor Protocol Number: GF22002 | Start Date*: 2023-03-07 |
| Sponsor Name:Ginefiv | ||
| Full Title: Protocol with progestin-primed ovarian stimulation (PPOS) starting on day 5 versus protocol with progestin-primed ovarian stimulation (PPOS) in a conventional regimen from the start of the ovaria... | ||
| Medical condition: Number of MII oocytes obtained in both groups | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2022-000753-80 | Sponsor Protocol Number: 000298 | Start Date*: 2022-08-04 | |||||||||||
| Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||
| Full Title: A randomised, assessor-blind, active-controlled, parallel-group, dose-finding trial to investigate the efficacy and safety of FE 999302 for triggering of final follicular maturation in women underg... | |||||||||||||
| Medical condition: Infertility | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: ES (Prematurely Ended) CZ (Prematurely Ended) DK (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2014-001743-20 | Sponsor Protocol Number: 1403-MAD-013-AR | Start Date*: 2015-07-30 |
| Sponsor Name:IVI Madrid | ||
| Full Title: A Multicentre, prospective, randomised clinical trial comparing the cost and efficacy of corifolitropina alfa vs Recombinant FSH and / or HP-hMG | ||
| Medical condition: The study is proposed to determine the level of compliance and pharmacoeconomic impact of three protocols for controlled ovarian stimulation in women participating in oocyte donation program | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-002214-77 | Sponsor Protocol Number: 1504-MAD-024-AR | Start Date*: 2016-05-05 |
| Sponsor Name:IVI Madrid | ||
| Full Title: Prospective randomized clinical trial to test the efficacy of a biosimilar recombinant FSH (Bemfola) vs. urinary FSH (Fostipur) in an oocyte donation program | ||
| Medical condition: The proposed study is to determine the efficacy of a recombinant FSH biosimilar vs. urinary FSH in oocyte donation program | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-005762-28 | Sponsor Protocol Number: 1512-VLC-066-EB | Start Date*: 2016-04-06 |
| Sponsor Name:IVI Valencia | ||
| Full Title: Analysis of follicular steroid synthesis during controlled ovarian stimulation with recombinant FSH vs HMG in GnRH antagonist cycles | ||
| Medical condition: Women undergoing ovarian stimulation for oocyte donation | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2019-001342-18 | Sponsor Protocol Number: IB-0319-001 | Start Date*: 2019-08-19 |
| Sponsor Name:Instituto Bernabeu | ||
| Full Title: CONVENTIONAL STIMULATION IN FOLICULAR PHASE VS. STIMULATION IN LUTEA PHASE IN PATIENTS WITH SUBOPTIMA RESPONSE. RANDOMIZED CLINICAL TRIAL. SUBLUTEAL STUDY | ||
| Medical condition: Suboptimal response of ovarian stimulation | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-002425-21 | Sponsor Protocol Number: 11054 | Start Date*: 2012-02-10 |
| Sponsor Name:University of Nottingham | ||
| Full Title: Efficacy of Dehydroepiandrosterone to overcome the effect of ovarian aging | ||
| Medical condition: Women having low ovarian reserve undergoing IVF/ICSI treatment | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2021-002467-22 | Sponsor Protocol Number: FSD-PSE-2021-09 | Start Date*: 2021-07-02 |
| Sponsor Name:Fundacion Santiago Dexeus Font | ||
| Full Title: Dual Trigger vs. GnRH-a Trigger for Elective Fertility Preservation. A randomized controlled trial. | ||
| Medical condition: This study is a randomized controlled, superiority trial comparing the number of MII oocytes following final follicle maturation with dual trigger (250 μg rhCG + 0.2mg Triptorelin) or GnRH-a trigge... | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2022-003177-32 | Sponsor Protocol Number: IBMR31 | Start Date*: 2022-11-17 |
| Sponsor Name:Instituto Bernabeu | ||
| Full Title: Continuous ovarian stimulation in DUOSTIM cycles. | ||
| Medical condition: Patients with predictive indicators of low ovarian response and who undergo double ovarian stimulation (DUOSTIM). | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-002040-24 | Sponsor Protocol Number: FI028.DEX001.2019 | Start Date*: 2020-04-14 |
| Sponsor Name:Dextra fertility clinic [...] | ||
| Full Title: Iron defiency as an ignored cause of infertility | ||
| Medical condition: Infertility | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: FI (Prematurely Ended) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
